{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:09:51Z","timestamp":1778126991051,"version":"3.51.4"},"publisher-location":"Cham","reference-count":244,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030217365","type":"print"},{"value":"9783030217372","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-21737-2_5","type":"book-chapter","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T18:02:33Z","timestamp":1563818553000},"page":"63-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cannabinoids and Cardiovascular System"],"prefix":"10.1007","author":[{"given":"Alexander I.","family":"Bondarenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"1","key":"5_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00281-009-0145-8","volume":"31","author":"P Pacher","year":"2009","unstructured":"Pacher P, Steffens S (2009) The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol 31(1):63\u201377","journal-title":"Semin Immunopathol"},{"issue":"14","key":"5_CR2","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","volume":"110","author":"S Batkai","year":"2004","unstructured":"Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J et\u00a0al (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110(14):1996\u20132002","journal-title":"Circulation"},{"issue":"35","key":"5_CR3","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.2174\/0929867321666140915141332","volume":"21","author":"F Carbone","year":"2014","unstructured":"Carbone F, Mach F, Vuilleumier N, Montecucco F (2014) Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases. Curr Med Chem 21(35):4046\u20134058","journal-title":"Curr Med Chem"},{"issue":"11","key":"5_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","volume":"17","author":"G Godlewski","year":"2010","unstructured":"Godlewski G, Alapafuja SO, Batkai S, Nikas SP, Cinar R, Offertaler L et al (2010) Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem Biol 17(11):1256\u20131266","journal-title":"Chem Biol"},{"issue":"1-3","key":"5_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2012.03.027","volume":"684","author":"JJ Hopps","year":"2012","unstructured":"Hopps JJ, Dunn WR, Randall MD (2012) Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension. Eur J Pharmacol 684(1-3):102\u2013107","journal-title":"Eur J Pharmacol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.yjmcc.2018.01.002","volume":"115","author":"AI Bondarenko","year":"2018","unstructured":"Bondarenko AI, Panasiuk O, Okhai I, Montecucco F, Brandt KJ, Mach F (2018) Ca2+-dependent potassium channels and cannabinoid signaling in the endothelium of apolipoprotein E knockout mice before plaque formation. J Mol Cell Cardiol 115:54\u201363","journal-title":"J Mol Cell Cardiol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"824093","DOI":"10.1155\/2012\/824093","volume":"2012","author":"LS Capettini","year":"2012","unstructured":"Capettini LS, Savergnini SQ, da Silva RF, Stergiopulos N, Santos RA, Mach F et al (2012) Update on the role of cannabinoid receptors after ischemic stroke. Mediat Inflamm 2012:824093","journal-title":"Mediat Inflamm"},{"issue":"6","key":"5_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","volume":"33","author":"F Montecucco","year":"2012","unstructured":"Montecucco F, Di Marzo V (2012) At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. Trends Pharmacol Sci 33(6):331\u2013340","journal-title":"Trends Pharmacol Sci"},{"issue":"1607","key":"5_CR9","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","volume":"367","author":"RG Pertwee","year":"2012","unstructured":"Pertwee RG (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond Ser B Biol Sci 367(1607):3353\u20133363","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"7","key":"5_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1753944718773690","volume":"12","author":"VM Martin Gimenez","year":"2018","unstructured":"Martin Gimenez VM, Noriega SE, Kassuha DE, Fuentes LB, Manucha W (2018) Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis 12(7):177\u2013190","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"5_CR11","doi-asserted-by":"crossref","unstructured":"Sierra S, Luquin N, Navarro-Otano J (2017) The endocannabinoid system in cardiovascular function: novel insights and clinical implications. Clin Auton Res 8","DOI":"10.1007\/s10286-017-0488-5"},{"issue":"6","key":"5_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/head.12570","volume":"55","author":"EP Baron","year":"2015","unstructured":"Baron EP (2015) Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it\u2019s been. Headache 55(6):885\u2013916","journal-title":"Headache"},{"issue":"Pt B","key":"5_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.yebeh.2017.01.031","volume":"70","author":"V Wolff","year":"2017","unstructured":"Wolff V, Jouanjus E (2017) Strokes are possible complications of cannabinoids use. Epilepsy Behav 70(Pt B):355\u2013363","journal-title":"Epilepsy Behav"},{"issue":"3","key":"5_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","volume":"15","author":"P Pacher","year":"2017","unstructured":"Pacher P, Steffens S, Hasko G, Schindler TH, Kunos G (2017) Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol 15(3):151\u2013166","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40119-017-0102-x","volume":"7","author":"A Singh","year":"2018","unstructured":"Singh A, Saluja S, Kumar A, Agrawal S, Thind M, Nanda S et al (2018) Cardiovascular complications of marijuana and related substances: a review. Cardiol Ther 7(1):45\u201359","journal-title":"Cardiol Ther"},{"issue":"3563","key":"5_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.140.3563.175","volume":"140","author":"M Lerner","year":"1963","unstructured":"Lerner M (1963) Marihuana: tetrahydrocannabinol and related compounds. Science 140(3563):175\u2013176","journal-title":"Science"},{"issue":"6284","key":"5_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346(6284):561\u2013564","journal-title":"Nature"},{"issue":"6441","key":"5_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61\u201365","journal-title":"Nature"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.pa.35.040195.003135","volume":"35","author":"AC Howlett","year":"1995","unstructured":"Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607\u2013634","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"5_CR20","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/1440-1681.12450","volume":"42","author":"Z Guo","year":"2015","unstructured":"Guo Z, Liu YX, Yuan F, Ma HJ, Maslov L, Zhang Y (2015) Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats. Clin Exp Pharmacol Physiol 42(9):950\u2013955","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"5_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brainresbull.2009.01.011","volume":"79","author":"M Schley","year":"2009","unstructured":"Schley M, Stander S, Kerner J, Vajkoczy P, Schupfer G, Dusch M et al (2009) Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Res Bull 79(5):333\u2013337","journal-title":"Brain Res Bull"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1196\/annals.1432.037","volume":"1139","author":"A Brusco","year":"2008","unstructured":"Brusco A, Tagliaferro PA, Saez T, Onaivi ES (2008) Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 1139:450\u2013457","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"5_CR23","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nn.2874","volume":"14","author":"ZX Xi","year":"2011","unstructured":"Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR et al (2011) Brain cannabinoid CB(2) receptors modulate cocaine\u2019s actions in mice. Nat Neurosci 14(9):1160\u20131166","journal-title":"Nat Neurosci"},{"issue":"10","key":"5_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","volume":"67","author":"H Ishiguro","year":"2010","unstructured":"Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y et al (2010) Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 67(10):974\u2013982","journal-title":"Biol Psychiatry"},{"issue":"4","key":"5_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","volume":"90","author":"AV Stempel","year":"2016","unstructured":"Stempel AV, Stumpf A, Zhang HY, Ozdogan T, Pannasch U, Theis AK et al (2016) Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 90(4):795\u2013809","journal-title":"Neuron"},{"issue":"1","key":"5_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215(1):89\u201397","journal-title":"Biochem Biophys Res Commun"},{"issue":"5090","key":"5_CR27","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946\u20131949","journal-title":"Science"},{"issue":"1","key":"5_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83\u201390","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"5_CR29","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI119677","volume":"100","author":"DG Deutsch","year":"1997","unstructured":"Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK et al (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100(6):1538\u20131546","journal-title":"J Clin Invest"},{"issue":"3","key":"5_CR30","doi-asserted-by":"publisher","first-page":"H1344","DOI":"10.1152\/ajpheart.00537.2004","volume":"288","author":"KM Gauthier","year":"2005","unstructured":"Gauthier KM, Baewer DV, Hittner S, Hillard CJ, Nithipatikom K, Reddy DS et al (2005) Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol 288(3):H1344\u2013H1351","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"5_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1006\/bbrc.1998.8187","volume":"243","author":"T Sugiura","year":"1998","unstructured":"Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243(3):838\u2013843","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2015.01.012","volume":"403","author":"M Szekeres","year":"2015","unstructured":"Szekeres M, Nadasy GL, Turu G, Soltesz-Katona E, Benyo Z, Offermanns S et al (2015) Endocannabinoid-mediated modulation of Gq\/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension. Mol Cell Endocrinol 403:46\u201356","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"5_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389\u2013462","journal-title":"Pharmacol Rev"},{"issue":"7","key":"5_CR34","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0735-1097(01)01671-0","volume":"38","author":"JA Wagner","year":"2001","unstructured":"Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK et al (2001) Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 38(7):2048\u20132054","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/eurheartj\/ehr029","volume":"32","author":"A Quercioli","year":"2011","unstructured":"Quercioli A, Pataky Z, Vincenti G, Makoundou V, Di Marzo V, Montecucco F et al (2011) Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J 32(11):1369\u20131378","journal-title":"Eur Heart J"},{"issue":"2","key":"5_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","volume":"205","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Matias I, Lenglet S, Petrosino S, Burger F, Pelli G et al (2009) Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis. Atherosclerosis 205(2):433\u2013441","journal-title":"Atherosclerosis"},{"issue":"5","key":"5_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063449","volume":"8","author":"NS Lobato","year":"2013","unstructured":"Lobato NS, Filgueira FP, Prakash R, Giachini FR, Ergul A, Carvalho MH et al (2013) Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats. PLoS One 8(5):e63449","journal-title":"PLoS One"},{"issue":"6","key":"5_CR38","doi-asserted-by":"publisher","first-page":"H1155","DOI":"10.1152\/ajpheart.00107.2018","volume":"314","author":"PW Pires","year":"2018","unstructured":"Pires PW (2018) Cannabinoids during ischemic strokes: friends or foes? Am J Physiol Heart Circ Physiol 314(6):H1155\u2013H11H6","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"5_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/bbrc.1996.1766","volume":"229","author":"MD Randall","year":"1996","unstructured":"Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM et al (1996) An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229(1):114\u2013120","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.pharep.2017.06.011","volume":"69","author":"E Lopez-Dyck","year":"2017","unstructured":"Lopez-Dyck E, Andrade-Urzua F, Elizalde A, Ferrer-Villada T, Dagnino-Acosta A, Huerta M et al (2017) ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms. Pharmacol Rep 69(6):1131\u20131139","journal-title":"Pharmacol Rep"},{"issue":"Pt 3","key":"5_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1042\/bj3460835","volume":"346","author":"J Liu","year":"2000","unstructured":"Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A et al (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346(Pt 3):835\u2013840","journal-title":"Biochem J"},{"issue":"7","key":"5_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S Batkai","year":"2001","unstructured":"Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J et\u00a0al (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7(7):827\u2013832","journal-title":"Nat Med"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejphar.2014.02.016","volume":"729","author":"E Sanchez-Pastor","year":"2014","unstructured":"Sanchez-Pastor E, Andrade F, Sanchez-Pastor JM, Elizalde A, Huerta M, Virgen-Ortiz A et al (2014) Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. Eur J Pharmacol 729:100\u2013106","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5_CR44","doi-asserted-by":"publisher","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","volume":"293","author":"S Batkai","year":"2007","unstructured":"Batkai S, Mukhopadhyay P, Harvey-White J, Kechrid R, Pacher P, Kunos G (2007) Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am J Physiol Heart Circ Physiol 293(3):H1689\u2013H1695","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3\u20134","key":"5_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.prostaglandins.2009.04.006","volume":"89","author":"HB Bradshaw","year":"2009","unstructured":"Bradshaw HB, Lee SH, McHugh D (2009) Orphan endogenous lipids and orphan GPCRs: a good match. Prostaglandins Other Lipid Mediat 89(3\u20134):131\u2013134","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"11","key":"5_CR46","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1002\/jcb.23245","volume":"112","author":"S Burstein","year":"2011","unstructured":"Burstein S, McQuain C, Ross A, Salmonsen R, Zurier RE (2011) Resolution of inflammation by N-arachidonoylglycine. J Cell Biochem 112(11):3227\u20133233","journal-title":"J Cell Biochem"},{"issue":"5","key":"5_CR47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","volume":"152","author":"AJ Brown","year":"2007","unstructured":"Brown AJ (2007) Novel cannabinoid receptors. Br J Pharmacol 152(5):567\u2013575","journal-title":"Br J Pharmacol"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","volume":"80","author":"A Irving","year":"2017","unstructured":"Irving A, Abdulrazzaq G, Chan SLF, Penman J, Harvey J, Alexander SPH (2017) Cannabinoid receptor-related orphan G protein-coupled receptors. Adv Pharmacol 80:223\u2013247","journal-title":"Adv Pharmacol"},{"issue":"8-9","key":"5_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.lfs.2012.06.039","volume":"92","author":"P Zhao","year":"2013","unstructured":"Zhao P, Abood ME (2013) GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors. Life Sci 92(8-9):453\u2013457","journal-title":"Life Sci"},{"issue":"5","key":"5_CR50","first-page":"987","volume":"116","author":"F Montecucco","year":"2016","unstructured":"Montecucco F, Bondarenko AI, Lenglet S, Burger F, Piscitelli F, Carbone F et al (2016) Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis. Thromb Haemost 116(5):987\u2013997","journal-title":"Thromb Haemost"},{"issue":"2","key":"5_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/138161206775193073","volume":"12","author":"M Oz","year":"2006","unstructured":"Oz M (2006) Receptor-independent effects of endocannabinoids on ion channels. Curr Pharm Des 12(2):227\u2013239","journal-title":"Curr Pharm Des"},{"issue":"2","key":"5_CR52","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.00744.x","volume":"161","author":"A Bondarenko","year":"2010","unstructured":"Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, Graier WF (2010) GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol 161(2):308\u2013320","journal-title":"Br J Pharmacol"},{"issue":"2","key":"5_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00424-011-0977-7","volume":"462","author":"AI Bondarenko","year":"2011","unstructured":"Bondarenko AI, Malli R, Graier WF (2011) The GPR55 agonist lysophosphatidylinositol directly activates intermediate-conductance Ca2+-activated K+ channels. Pflugers Arch 462(2):245\u2013255","journal-title":"Pflugers Arch"},{"issue":"14","key":"5_CR54","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/092986710790980050","volume":"17","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17(14):1360\u20131381","journal-title":"Curr Med Chem"},{"issue":"11","key":"5_CR55","doi-asserted-by":"publisher","first-page":"H1415","DOI":"10.1152\/ajpheart.00976.2012","volume":"304","author":"P Bednarczyk","year":"2013","unstructured":"Bednarczyk P, Koziel A, Jarmuszkiewicz W, Szewczyk A (2013) Large-conductance Ca2+-activated potassium channel in mitochondria of endothelial EA.hy926 cells. Am J Physiol Heart Circ Physiol 304(11):H1415\u2013H1427","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"5_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00424-013-1224-1","volume":"465","author":"AI Bondarenko","year":"2013","unstructured":"Bondarenko AI, Jean-Quartier C, Malli R, Graier WF (2013) Characterization of distinct single-channel properties of Ca2+ inward currents in mitochondria. Pflugers Arch 465(7):997\u20131010","journal-title":"Pflugers Arch"},{"issue":"7","key":"5_CR57","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","volume":"29","author":"D Ryan","year":"2009","unstructured":"Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B (2009) Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 29(7):2053\u20132063","journal-title":"J Neurosci"},{"issue":"4","key":"5_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nn.3053","volume":"15","author":"G Benard","year":"2012","unstructured":"Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E et al (2012) Mitochondrial CB1 receptors regulate neuronal energy metabolism. Nat Neurosci 15(4):558\u2013564","journal-title":"Nat Neurosci"},{"key":"5_CR59","doi-asserted-by":"crossref","first-page":"425289","DOI":"10.1155\/2009\/425289","volume":"2009","author":"SE O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan SE, Kendall DA, Randall MD (2009) Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARgamma). PPAR Res 2009:425289","journal-title":"PPAR Res"},{"issue":"2","key":"5_CR60","first-page":"707","volume":"294","author":"N Niederhoffer","year":"2000","unstructured":"Niederhoffer N, Szabo B (2000) Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther 294(2):707\u2013713","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"5_CR61","first-page":"343","volume":"66","author":"E Grzeda","year":"2015","unstructured":"Grzeda E, Schlicker E, Luczaj W, Harasim E, Baranowska-Kuczko M, Malinowska B (2015) Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. J Physiol Pharmacol 66(3):343\u2013353","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"5_CR62","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00210-003-0755-y","volume":"367","author":"N Niederhoffer","year":"2003","unstructured":"Niederhoffer N, Schmid K, Szabo B (2003) The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn Schmiedeberg\u2019s Arch Pharmacol 367(5):434\u2013443","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"2","key":"5_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/PL00005041","volume":"356","author":"B Malinowska","year":"1997","unstructured":"Malinowska B, Godlewski G, Bucher B, Schlicker E (1997) Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedeberg\u2019s Arch Pharmacol 356(2):197\u2013202","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"6","key":"5_CR64","doi-asserted-by":"publisher","first-page":"C924","DOI":"10.1152\/ajpcell.00228.2011","volume":"302","author":"Q Li","year":"2012","unstructured":"Li Q, Ma HJ, Song SL, Shi M, Li DP, Zhang Y (2012) Effects of anandamide on potassium channels in rat ventricular myocytes: a suppression of I(to) and augmentation of K(ATP) channels. Am J Phys Cell Physiol 302(6):C924\u2013C930","journal-title":"Am J Phys Cell Physiol"},{"key":"5_CR65","first-page":"3485","volume":"171","author":"LT Kury Al","year":"2014","unstructured":"Al Kury LT, Yang KH, Thayyullathil FT, Rajesh M, Ali RM, Shuba YM et al (2014) Effects of endogenous cannabinoid anandamide on cardiac Na\/Ca exchanger. Cell Calcium 171:3485\u20133498","journal-title":"Cell Calcium"},{"issue":"4","key":"5_CR66","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/cvr\/cvp369","volume":"85","author":"P Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay P, Rajesh M, Batkai S, Patel V, Kashiwaya Y, Liaudet L et al (2010) CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res 85(4):773\u2013784","journal-title":"Cardiovasc Res"},{"issue":"2-3","key":"5_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejphar.2006.12.016","volume":"559","author":"JY Su","year":"2007","unstructured":"Su JY, Vo AC (2007) 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1\/2 signaling. Eur J Pharmacol 559(2-3):189\u2013195","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.bjp.0703521","volume":"131","author":"I Bossche Van den","year":"2000","unstructured":"Van den Bossche I, Vanheel B (2000) Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Br J Pharmacol 131(1):85\u201393","journal-title":"Br J Pharmacol"},{"issue":"11","key":"5_CR69","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1139\/y06-058","volume":"84","author":"J Breyne","year":"2006","unstructured":"Breyne J, Van de Voorde J, Vanheel B (2006) Characterization of the vasorelaxation to methanandamide in rat gastric arteries. Can J Physiol Pharmacol 84(11):1121\u20131132","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"5_CR70","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/sj.bjp.0701690","volume":"123","author":"T Chataigneau","year":"1998","unstructured":"Chataigneau T, Feletou M, Thollon C, Villeneuve N, Vilaine JP, Duhault J et\u00a0al (1998) Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 123(5):968\u2013974","journal-title":"Br J Pharmacol"},{"issue":"2","key":"5_CR71","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","volume":"153","author":"M Rajesh","year":"2008","unstructured":"Rajesh M, Mukhopadhyay P, Hasko G, Huffman JW, Mackie K, Pacher P (2008) CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol 153(2):347\u2013357","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00424-010-0898-x","volume":"461","author":"AI Bondarenko","year":"2011","unstructured":"Bondarenko AI, Malli R, Graier WF (2011) The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+-activated large-conductance K+ channels in endothelial cells. Pflugers Arch 461(1):177\u2013189","journal-title":"Pflugers Arch"},{"key":"5_CR73","unstructured":"Stanley CP, Hind WH, Tufarelli C, O\u2019Sullivan SE (2015) Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovasc Res 19"},{"issue":"22","key":"5_CR74","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1111\/bph.13312","volume":"172","author":"WS Ho","year":"2015","unstructured":"Ho WS, Zheng X, Zhang DX (2015) Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. Br J Pharmacol 172(22):5251\u20135264","journal-title":"Br J Pharmacol"},{"key":"5_CR75","unstructured":"Suleimani YMA, Hiley CR (2010) Lysophosphatidylinositol (LPI) mediates vasorelaxation of the rat mesenteric resistance artery and induces calcium release in rat mesenteric artery endothelial cells. In: Proceedings of the British Pharmacological Society Winter Meeting 2010, London, 81(1)"},{"issue":"4","key":"5_CR76","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.bjp.0705313","volume":"139","author":"P Lepicier","year":"2003","unstructured":"Lepicier P, Bouchard JF, Lagneux C, Lamontagne D (2003) Endocannabinoids protect the rat isolated heart against ischaemia. Br J Pharmacol 139(4):805\u2013815","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR77","first-page":"242","volume":"99","author":"D Lamontagne","year":"2006","unstructured":"Lamontagne D, Lepicier P, Lagneux C, Bouchard JF (2006) The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia. Arch Mal Coeur Vaiss 99(3):242\u2013246","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"1","key":"5_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","volume":"50","author":"P Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay P, Horvath B, Rajesh M, Matsumoto S, Saito K, Batkai S et al (2011) Fatty acid amide hydrolase is a key regulator of the endocannabinoid-induced myocardial tissue injury. Free Radic Biol Med 50(1):179\u2013195","journal-title":"Free Radic Biol Med"},{"issue":"1-2","key":"5_CR79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2004.02.034","volume":"489","author":"FM Mo","year":"2004","unstructured":"Mo FM, Offertaler L, Kunos G (2004) Atypical cannabinoid stimulates endothelial cell migration via a Gi\/Go-coupled receptor distinct from CB1, CB2 or EDG. Eur J Pharmacol 489(1-2):21\u201327","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"5_CR80","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/j.1476-5381.2010.00841.x","volume":"160","author":"X Zhang","year":"2010","unstructured":"Zhang X, Maor Y, Wang JF, Kunos G, Groopman JE (2010) Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br J Pharmacol 160(7):1583\u20131594","journal-title":"Br J Pharmacol"},{"issue":"20","key":"5_CR81","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","volume":"117","author":"S Pisanti","year":"2011","unstructured":"Pisanti S, Picardi P, Prota L, Proto MC, Laezza C, McGuire PG et al (2011) Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. Blood 117(20):5541\u20135550","journal-title":"Blood"},{"issue":"2","key":"5_CR82","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.bjp.0707517","volume":"153","author":"F Mach","year":"2008","unstructured":"Mach F, Montecucco F, Steffens S (2008) Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol 153(2):290\u2013298","journal-title":"Br J Pharmacol"},{"issue":"3859","key":"5_CR83","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.162.3859.1234","volume":"162","author":"AT Weil","year":"1968","unstructured":"Weil AT, Zinberg NE, Nelsen JM (1968) Clinical and psychological effects of marihuana in man. Science 162(3859):1234\u20131242","journal-title":"Science"},{"issue":"4","key":"5_CR84","first-page":"349","volume":"23","author":"LE Hollister","year":"1971","unstructured":"Hollister LE (1971) Actions of various marihuana derivatives in man. Pharmacol Rev 23(4):349\u2013357","journal-title":"Pharmacol Rev"},{"issue":"1","key":"5_CR85","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","volume":"28","author":"IG Karniol","year":"1974","unstructured":"Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA (1974) Cannabidiol interferes with the effects of delta 9\u00a0\u2013 tetrahydrocannabinol in man. Eur J Pharmacol 28(1):172\u2013177","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5_CR86","first-page":"339","volume":"23","author":"GF Kiplinger","year":"1971","unstructured":"Kiplinger GF, Manno JE (1971) Dose-response relationships to cannabis in human subjects. Pharmacol Rev 23(4):339\u2013347","journal-title":"Pharmacol Rev"},{"issue":"3","key":"5_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02737700","volume":"15","author":"BE Hoozen Van","year":"1997","unstructured":"Van Hoozen BE, Cross CE (1997) Marijuana. Respiratory tract effects. Clin Rev Allergy Immunol 15(3):243\u2013269","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"5_CR88","doi-asserted-by":"publisher","first-page":"448","DOI":"10.7326\/0003-4819-89-4-448","volume":"89","author":"A Gash","year":"1978","unstructured":"Gash A, Karliner JS, Janowsky D, Lake CR (1978) Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men. Ann Intern Med 89(4):448\u2013452","journal-title":"Ann Intern Med"},{"issue":"5","key":"5_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM197208032870501","volume":"287","author":"P Beaconsfield","year":"1972","unstructured":"Beaconsfield P, Ginsburg J, Rainsbury R (1972) Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med 287(5):209\u2013212","journal-title":"N Engl J Med"},{"issue":"2","key":"5_CR90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1600-0447.1989.tb08579.x","volume":"79","author":"RJ Mathew","year":"1989","unstructured":"Mathew RJ, Wilson WH, Tant SR (1989) Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 79(2):118\u2013128","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"5_CR91","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/jcbfm.1992.106","volume":"12","author":"RJ Mathew","year":"1992","unstructured":"Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE (1992) Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 12(5):750\u2013758","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"5_CR92","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hup.832","volume":"22","author":"DS O\u2019Leary","year":"2007","unstructured":"O\u2019Leary DS, Block RI, Koeppel JA, Schultz SK, Magnotta VA, Ponto LB et al (2007) Effects of smoking marijuana on focal attention and brain blood flow. Hum Psychopharmacol 22(3):135\u2013148","journal-title":"Hum Psychopharmacol"},{"key":"5_CR93","doi-asserted-by":"crossref","unstructured":"Rezkalla S, Kloner RA (2018) Cardiovascular effects of marijuana. Trends Cardiovasc Med","DOI":"10.1016\/j.tcm.2018.11.004"},{"issue":"2","key":"5_CR94","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1742-1241.2007.01505.x","volume":"62","author":"P Korantzopoulos","year":"2008","unstructured":"Korantzopoulos P, Liu T, Papaioannides D, Li G, Goudevenos JA (2008) Atrial fibrillation and marijuana smoking. Int J Clin Pract 62(2):308\u2013313","journal-title":"Int J Clin Pract"},{"issue":"3","key":"5_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","volume":"15","author":"P Pacher","year":"2018","unstructured":"Pacher P, Steffens S, Hasko G, Schindler TH, Kunos G (2018) Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol 15(3):151\u2013166","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"5_CR96","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/cpt1972135part1671","volume":"13","author":"JL Weiss","year":"1972","unstructured":"Weiss JL, Watanabe AM, Lemberger L, Tamarkin NR, Cardon PV (1972) Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther 13(5):671\u2013684","journal-title":"Clin Pharmacol Ther"},{"key":"5_CR97","first-page":"2(12)","volume":"15","author":"KA Jadoon","year":"2017","unstructured":"Jadoon KA, Tan GD, O\u2019Sullivan SE (2017) A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight 15:2(12)","journal-title":"JCI Insight"},{"issue":"3","key":"5_CR98","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.2042-7158.1974.tb09252.x","volume":"26","author":"RR Vollmer","year":"1974","unstructured":"Vollmer RR, Cavero I, Ertel RJ, Solomon TA, Buckley JP (1974) Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol 26(3):186\u2013192","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"5_CR99","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/01.CIR.53.4.703","volume":"53","author":"C Kanakis Jr","year":"1976","unstructured":"Kanakis C Jr, Pouget JM, Rosen KM (1976) The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation 53(4):703\u2013707","journal-title":"Circulation"},{"issue":"6","key":"5_CR100","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/00000542-197506000-00008","volume":"42","author":"LA Malit","year":"1975","unstructured":"Malit LA, Johnstone RE, Bourke DI, Kulp RA, Klein V, Smith TC (1975) Intravenous delta9-Tetrahydrocannabinol: effects of ventilatory control and cardiovascular dynamics. Anesthesiology 42(6):666\u2013673","journal-title":"Anesthesiology"},{"issue":"3","key":"5_CR101","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cpt1975183287","volume":"18","author":"NL Benowitz","year":"1975","unstructured":"Benowitz NL, Jones RT (1975) Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 18(3):287\u2013297","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"5_CR102","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.bjp.0704100","volume":"133","author":"SM Gardiner","year":"2001","unstructured":"Gardiner SM, March JE, Kemp PA, Bennett T (2001) Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br J Pharmacol 133(3):445\u2013453","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR103","first-page":"1030","volume":"281","author":"KD Lake","year":"1997","unstructured":"Lake KD, Compton DR, Varga K, Martin BR, Kunos G (1997) Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281(3):1030\u20131037","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"5_CR104","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/01.HYP.28.4.682","volume":"28","author":"K Varga","year":"1996","unstructured":"Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28(4):682\u2013686","journal-title":"Hypertension"},{"issue":"5","key":"5_CR105","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","volume":"29","author":"KD Lake","year":"1997","unstructured":"Lake KD, Martin BR, Kunos G, Varga K (1997) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29(5):1204\u20131210","journal-title":"Hypertension"},{"issue":"7","key":"5_CR106","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1111\/j.1476-5381.2011.01747.x","volume":"165","author":"B Malinowska","year":"2012","unstructured":"Malinowska B, Baranowska-Kuczko M, Schlicker E (2012) Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Br J Pharmacol 165(7):2073\u20132088","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR107","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","volume":"278","author":"K Varga","year":"1995","unstructured":"Varga K, Lake K, Martin BR, Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278(3):279\u2013283","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"5_CR108","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","volume":"118","author":"EJ Ishac","year":"1996","unstructured":"Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118(8):2023\u20132028","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR109","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1476-5381.2009.00579.x","volume":"160","author":"A Zakrzeska","year":"2010","unstructured":"Zakrzeska A, Schlicker E, Baranowska M, Kozlowska H, Kwolek G, Malinowska B (2010) A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. Br J Pharmacol 160(3):574\u2013584","journal-title":"Br J Pharmacol"},{"issue":"6","key":"5_CR110","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00210-001-0498-6","volume":"364","author":"B Malinowska","year":"2001","unstructured":"Malinowska B, Kwolek G, Gothert M (2001) Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedeberg\u2019s Arch Pharmacol 364(6):562\u2013569","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"Pt 2","key":"5_CR111","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1113\/jphysiol.2004.064824","volume":"558","author":"P Pacher","year":"2004","unstructured":"Pacher P, Batkai S, Kunos G (2004) Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J Physiol 558(Pt 2):647\u2013657","journal-title":"J Physiol"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00244930","volume":"240","author":"O Krayer","year":"1961","unstructured":"Krayer O (1961) The history of the Bezold-Jarisch effect. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 240:361\u2013368","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol"},{"issue":"2","key":"5_CR113","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","volume":"35","author":"Z Jarai","year":"2000","unstructured":"Jarai Z, Wagner JA, Goparaju SK, Wang L, Razdan RK, Sugiura T et al (2000) Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension 35(2):679\u2013684","journal-title":"Hypertension"},{"issue":"2","key":"5_CR114","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.bjp.0702337","volume":"126","author":"N Niederhoffer","year":"1999","unstructured":"Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126(2):457\u2013466","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5_CR115","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/sj.bjp.0704649","volume":"135","author":"SM Gardiner","year":"2002","unstructured":"Gardiner SM, March JE, Kemp PA, Bennett T (2002) Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135(8):1889\u20131896","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5_CR116","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/sj.bjp.0704750","volume":"136","author":"SM Gardiner","year":"2002","unstructured":"Gardiner SM, March JE, Kemp PA, Bennett T (2002) Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. Br J Pharmacol 136(4):581\u2013587","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR117","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cardiores.2004.03.024","volume":"63","author":"F Stanke-Labesque","year":"2004","unstructured":"Stanke-Labesque F, Mallaret M, Lefebvre B, Hardy G, Caron F, Bessard G (2004) 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. Cardiovasc Res 63(1):155\u2013160","journal-title":"Cardiovasc Res"},{"issue":"2","key":"5_CR118","first-page":"322","volume":"296","author":"B Vanheel","year":"2001","unstructured":"Vanheel B, Van de Voorde J (2001) Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J Pharmacol Exp Ther 296(2):322\u2013328","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"5_CR119","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bjp.0705810","volume":"142","author":"SE O\u2019Sullivan","year":"2004","unstructured":"O\u2019Sullivan SE, Kendall DA, Randall MD (2004) Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br J Pharmacol 142(3):435\u2013442","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5_CR120","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.bjp.0706218","volume":"145","author":"SE O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan SE, Kendall DA, Randall MD (2005) The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. Br J Pharmacol 145(4):514\u2013526","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR121","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.bjp.0705280","volume":"139","author":"WS Ho","year":"2003","unstructured":"Ho WS, Hiley CR (2003) Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx. Br J Pharmacol 139(3):585\u2013597","journal-title":"Br J Pharmacol"},{"issue":"Pt 3","key":"5_CR122","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1113\/jphysiol.2001.013489","volume":"539","author":"D Harris","year":"2002","unstructured":"Harris D, McCulloch AI, Kendall DA, Randall MD (2002) Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J Physiol 539(Pt 3):893\u2013902","journal-title":"J Physiol"},{"issue":"24","key":"5_CR123","doi-asserted-by":"publisher","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","volume":"96","author":"Z Jarai","year":"1999","unstructured":"Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR et al (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 96(24):14136\u201314141","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-3","key":"5_CR124","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejphar.2004.11.056","volume":"507","author":"SE O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan SE, Kendall DA, Randall MD (2005) Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. Eur J Pharmacol 507(1-3):211\u2013221","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"5_CR125","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.bjp.0707404","volume":"152","author":"E Herradon","year":"2007","unstructured":"Herradon E, Martin MI, Lopez-Miranda V (2007) Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol 152(5):699\u2013708","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR126","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1124\/jpet.108.144717","volume":"328","author":"G Godlewski","year":"2009","unstructured":"Godlewski G, Offertaler L, Osei-Hyiaman D, Mo FM, Harvey-White J, Liu J et\u00a0al (2009) The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels. J Pharmacol Exp Ther 328(1):351\u2013361","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"5_CR127","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bph.12180","volume":"169","author":"AI Bondarenko","year":"2013","unstructured":"Bondarenko AI, Drachuk K, Panasiuk O, Sagach V, Deak AT, Malli R et al (2013) N-arachidonoyl glycine suppresses Na+\/Ca2+ exchanger-mediated Ca2+ entry into endothelial cells and activates BK channels independently of G-protein coupled receptors. Br J Pharmacol 169(4):933\u2013948","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5_CR128","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00424-014-1467-5","volume":"466","author":"J Chemin","year":"2014","unstructured":"Chemin J, Cazade M, Lory P (2014) Modulation of T-type calcium channels by bioactive lipids. Pflugers Arch 466(4):689\u2013700","journal-title":"Pflugers Arch"},{"issue":"42","key":"5_CR129","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1523\/JNEUROSCI.2919-09.2009","volume":"29","author":"G Barbara","year":"2009","unstructured":"Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E et al (2009) T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci 29(42):13106\u201313114","journal-title":"J Neurosci"},{"key":"5_CR130","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuroscience.2015.11.039","volume":"313","author":"W Yang","year":"2016","unstructured":"Yang W, Li Q, Wang SY, Gao F, Qian WJ, Li F et al (2016) Cannabinoid receptor agonists modulate calcium channels in rat retinal Muller cells. Neuroscience 313:213\u2013224","journal-title":"Neuroscience"},{"issue":"4","key":"5_CR131","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.neuropharm.2011.05.024","volume":"61","author":"M Patil","year":"2011","unstructured":"Patil M, Patwardhan A, Salas MM, Hargreaves KM, Akopian AN (2011) Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons. Neuropharmacology 61(4):778\u2013788","journal-title":"Neuropharmacology"},{"issue":"5","key":"5_CR132","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1523\/JNEUROSCI.1565-06.2008","volume":"28","author":"AN Akopian","year":"2008","unstructured":"Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM (2008) Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J Neurosci 28(5):1064\u20131075","journal-title":"J Neurosci"},{"issue":"1-2","key":"5_CR133","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/emboj\/20.1.47","volume":"20","author":"F Maingret","year":"2001","unstructured":"Maingret F, Patel AJ, Lazdunski M, Honore E (2001) The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J 20(1-2):47\u201354","journal-title":"EMBO J"},{"issue":"5","key":"5_CR134","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/sj.bjp.0707436","volume":"152","author":"EL Veale","year":"2007","unstructured":"Veale EL, Buswell R, Clarke CE, Mathie A (2007) Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide. Br J Pharmacol 152(5):778\u2013786","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5_CR135","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.RES.0000219677.12988.e9","volume":"98","author":"A Olschewski","year":"2006","unstructured":"Olschewski A, Li Y, Tang B, Hanze J, Eul B, Bohle RM et al (2006) Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res 98(8):1072\u20131080","journal-title":"Circ Res"},{"issue":"1","key":"5_CR136","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.bjp.0705691","volume":"142","author":"MJ Gardener","year":"2004","unstructured":"Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH (2004) Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 142(1):192\u2013202","journal-title":"Br J Pharmacol"},{"key":"5_CR137","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.vph.2017.01.002","volume":"89","author":"AI Bondarenko","year":"2017","unstructured":"Bondarenko AI, Montecucco F, Panasiuk O, Sagach V, Sidoryak N, Brandt KJ et al (2017) GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na+-Ca2+ exchanger and endoplasmic reticulum Ca2+ refilling. Vasc Pharmacol 89:39\u201348","journal-title":"Vasc Pharmacol"},{"key":"5_CR138","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejphar.2016.11.040","volume":"794","author":"YM Suleimani Al","year":"2017","unstructured":"Al Suleimani YM, Al Mahruqi AS (2017) The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant. Eur J Pharmacol 794:209\u2013215","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"5_CR139","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.bjp.0706913","volume":"149","author":"A Bondarenko","year":"2006","unstructured":"Bondarenko A, Sagach V (2006) Na+-K+-ATPase is involved in the sustained ACh-induced hyperpolarization of endothelial cells from rat aorta. Br J Pharmacol 149(7):958\u2013965","journal-title":"Br J Pharmacol"},{"issue":"7","key":"5_CR140","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neuint.2003.08.009","volume":"44","author":"M Steffens","year":"2004","unstructured":"Steffens M, Feuerstein TJ (2004) Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex--involvement of Na(+)\/K(+)-ATPase. Neurochem Int 44(7):529\u2013538","journal-title":"Neurochem Int"},{"issue":"6 Pt 2","key":"5_CR141","first-page":"H1859","volume":"269","author":"EF Ellis","year":"1995","unstructured":"Ellis EF, Moore SF, Willoughby KA (1995) Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Phys 269(6 Pt 2):H1859\u2013H1864","journal-title":"Am J Phys"},{"issue":"2-3","key":"5_CR142","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(97)01237-5","volume":"335","author":"MD Randall","year":"1997","unstructured":"Randall MD, Kendall DA (1997) Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335(2-3):205\u2013209","journal-title":"Eur J Pharmacol"},{"issue":"1 Pt 2","key":"5_CR143","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.HYP.33.1.429","volume":"33","author":"JA Wagner","year":"1999","unstructured":"Wagner JA, Varga K, Jarai Z, Kunos G (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33(1 Pt 2):429\u2013434","journal-title":"Hypertension"},{"issue":"8","key":"5_CR144","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/sj.bjp.0701361","volume":"121","author":"F Plane","year":"1997","unstructured":"Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP (1997) Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121(8):1509\u20131511","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5_CR145","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/sj.bjp.0701546","volume":"122","author":"R White","year":"1997","unstructured":"White R, Hiley CR (1997) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122(8):1573\u20131584","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5_CR146","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/sj.bjp.0701601","volume":"122","author":"PM Zygmunt","year":"1997","unstructured":"Zygmunt PM, Hogestatt ED, Waldeck K, Edwards G, Kirkup AJ, Weston AH (1997) Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol 122(8):1679\u20131686","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5_CR147","first-page":"1146","volume":"286","author":"D Fulton","year":"1998","unstructured":"Fulton D, Quilley J (1998) Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J Pharmacol Exp Ther 286(3):1146\u20131151","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5_CR148","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s002100000229","volume":"361","author":"PM Zygmunt","year":"2000","unstructured":"Zygmunt PM, Sorgard M, Petersson J, Johansson R, Hogestatt ED (2000) Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. Naunyn Schmiedeberg\u2019s Arch Pharmacol 361(5):535\u2013542","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"6","key":"5_CR149","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/sj.bjp.0702452","volume":"126","author":"N Niederhoffer","year":"1999","unstructured":"Niederhoffer N, Szabo B (1999) Involvement of CB1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits. Br J Pharmacol 126(6):1383\u20131386","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR150","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","volume":"41","author":"MJ Mulvany","year":"1977","unstructured":"Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41(1):19\u201326","journal-title":"Circ Res"},{"issue":"1","key":"5_CR151","doi-asserted-by":"publisher","first-page":"H94","DOI":"10.1152\/ajpheart.00708.2010","volume":"300","author":"X Lu","year":"2011","unstructured":"Lu X, Kassab GS (2011) Assessment of endothelial function of large, medium, and small vessels: a unified myograph. Am J Physiol Heart Circ Physiol 300(1):H94\u2013H100","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2 Pt 2","key":"5_CR152","first-page":"H670","volume":"268","author":"BJ Falloon","year":"1995","unstructured":"Falloon BJ, Stephens N, Tulip JR, Heagerty AM (1995) Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Phys 268(2 Pt 2):H670\u2013H678","journal-title":"Am J Phys"},{"issue":"1 Pt 2","key":"5_CR153","first-page":"H375","volume":"274","author":"PF Pratt","year":"1998","unstructured":"Pratt PF, Hillard CJ, Edgemond WS, Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Phys 274(1 Pt 2):H375\u2013H381","journal-title":"Am J Phys"},{"issue":"3","key":"5_CR154","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1124\/mol.63.3.699","volume":"63","author":"L Offertaler","year":"2003","unstructured":"Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK et al (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63(3):699\u2013705","journal-title":"Mol Pharmacol"},{"issue":"6743","key":"5_CR155","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/22761","volume":"400","author":"PM Zygmunt","year":"1999","unstructured":"Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400(6743):452\u2013457","journal-title":"Nature"},{"issue":"Pt 1","key":"5_CR156","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1469-7793.2001.0095j.x","volume":"531","author":"M Begg","year":"2001","unstructured":"Begg M, Baydoun A, Parsons ME, Molleman A (2001) Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line. J Physiol 531(Pt 1):95\u2013104","journal-title":"J Physiol"},{"issue":"3","key":"5_CR157","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bjp.0702111","volume":"125","author":"R White","year":"1998","unstructured":"White R, Hiley CR (1998) The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br J Pharmacol 125(3):533\u2013541","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR158","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharep.2018.09.008","volume":"71","author":"J Weresa","year":"2018","unstructured":"Weresa J, Pedzinska-Betiuk A, Kossakowski R, Malinowska B (2018) Cannabinoid CB1 and CB2 receptors antagonists AM251 and AM630 differentially modulate the chronotropic and inotropic effects of isoprenaline in isolated rat atria. Pharmacol Rep 71(1):82\u201389","journal-title":"Pharmacol Rep"},{"issue":"2-3","key":"5_CR159","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C et al (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350(2-3):240\u2013244","journal-title":"FEBS Lett"},{"issue":"11","key":"5_CR160","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1097\/HJH.0b013e3282ef7a0a","volume":"25","author":"H Kozlowska","year":"2007","unstructured":"Kozlowska H, Baranowska M, Schlicker E, Kozlowski M, Laudanski J, Malinowska B (2007) Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. J Hypertens 25(11):2240\u20132248","journal-title":"J Hypertens"},{"issue":"7","key":"5_CR161","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","volume":"138","author":"WS Ho","year":"2003","unstructured":"Ho WS, Hiley CR (2003) Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br J Pharmacol 138(7):1320\u20131332","journal-title":"Br J Pharmacol"},{"issue":"Pt 2","key":"5_CR162","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1469-7793.1999.00539.x","volume":"520","author":"AT Chaytor","year":"1999","unstructured":"Chaytor AT, Martin PE, Evans WH, Randall MD, Griffith TM (1999) The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol 520(Pt 2):539\u2013550","journal-title":"J Physiol"},{"key":"5_CR163","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vph.2018.01.004","volume":"102","author":"AI Bondarenko","year":"2018","unstructured":"Bondarenko AI, Panasiuk O, Drachuk K, Montecucco F, Brandt KJ, Mach F (2018) The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells. Vasc Pharmacol 102:44\u201355","journal-title":"Vasc Pharmacol"},{"issue":"2","key":"5_CR164","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/hy0202.102702","volume":"39","author":"RD Bukoski","year":"2002","unstructured":"Bukoski RD, Batkai S, Jarai Z, Wang Y, Offertaler L, Jackson WF et al (2002) CB1 receptor antagonist SR141716A inhibits Ca2+-induced relaxation in CB1 receptor-deficient mice. Hypertension 39(2):251\u2013257","journal-title":"Hypertension"},{"issue":"3","key":"5_CR165","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2710.2011.01284.x","volume":"37","author":"RB Raffa","year":"2012","unstructured":"Raffa RB, Ward SJ (2012) CB(1)-independent mechanisms of Delta(9)-THCV, AM251 and SR141716 (rimonabant). J Clin Pharm Ther 37(3):260\u2013265","journal-title":"J Clin Pharm Ther"},{"issue":"5\u20136","key":"5_CR166","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ceca.2009.08.007","volume":"46","author":"H Hoddah","year":"2009","unstructured":"Hoddah H, Marcantoni A, Comunanza V, Carabelli V, Carbone E (2009) L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP\/PKA in GT1-7 hypothalamic neurons. Cell Calcium 46(5\u20136):303\u2013312","journal-title":"Cell Calcium"},{"issue":"7","key":"5_CR167","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/CAD.0000000000000246","volume":"26","author":"S Carpi","year":"2015","unstructured":"Carpi S, Fogli S, Romanini A, Pellegrino M, Adinolfi B, Podesta A et al (2015) AM251 induces apoptosis and G2\/M cell cycle arrest in A375 human melanoma cells. Anti-Cancer Drugs 26(7):754\u2013762","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"5_CR168","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.bjp.0704333","volume":"134","author":"R White","year":"2001","unstructured":"White R, Ho WS, Bottrill FE, Ford WR, Hiley CR (2001) Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134(4):921\u2013929","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5_CR169","first-page":"245","volume":"289","author":"N Ishioka","year":"1999","unstructured":"Ishioka N, Bukoski RD (1999) A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation. J Pharmacol Exp Ther 289(1):245\u2013250","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5_CR170","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00210-014-0961-9","volume":"387","author":"M Baranowska-Kuczko","year":"2014","unstructured":"Baranowska-Kuczko M, Kozlowska H, Kozlowski M, Schlicker E, Kloza M, Surazynski A et al (2014) Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. Naunyn Schmiedeberg\u2019s Arch Pharmacol 387(5):477\u2013486","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"3","key":"5_CR171","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.phrs.2012.05.004","volume":"66","author":"M Baranowska-Kuczko","year":"2012","unstructured":"Baranowska-Kuczko M, MacLean MR, Kozlowska H, Malinowska B (2012) Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. Pharmacol Res 66(3):251\u2013259","journal-title":"Pharmacol Res"},{"issue":"Pt A","key":"5_CR172","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.phrs.2016.08.028","volume":"113","author":"CP Stanley","year":"2016","unstructured":"Stanley CP, Hind WH, Tufarelli C, O\u2019Sullivan SE (2016) The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries. Pharmacol Res 113(Pt A):356\u2013363","journal-title":"Pharmacol Res"},{"issue":"5","key":"5_CR173","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bjp.0704340","volume":"134","author":"J Grainger","year":"2001","unstructured":"Grainger J, Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134(5):1003\u20131012","journal-title":"Br J Pharmacol"},{"issue":"5","key":"5_CR174","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.bjp.0707141","volume":"150","author":"WS Ho","year":"2007","unstructured":"Ho WS, Randall MD (2007) Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150(5):641\u2013651","journal-title":"Br J Pharmacol"},{"issue":"2-3","key":"5_CR175","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0014-2999(01)00833-0","volume":"415","author":"S Kagota","year":"2001","unstructured":"Kagota S, Yamaguchi Y, Nakamura K, Sugiura T, Waku K, Kunitomo M (2001) 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur J Pharmacol 415(2-3):233\u2013238","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5_CR176","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(98)00777-8","volume":"362","author":"R Mechoulam","year":"1998","unstructured":"Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M (1998) Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur J Pharmacol 362(1):R1\u2013R3","journal-title":"Eur J Pharmacol"},{"key":"5_CR177","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2014.02.001","volume":"81C","author":"CP Stanley","year":"2014","unstructured":"Stanley CP, O\u2019Sullivan SE (2014) Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. Pharmacol Res 81C:74\u201382","journal-title":"Pharmacol Res"},{"issue":"Pt 2","key":"5_CR178","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1113\/jphysiol.2005.094292","volume":"568","author":"IM Poblete","year":"2005","unstructured":"Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP (2005) Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol 568(Pt 2):539\u2013551","journal-title":"J Physiol"},{"key":"5_CR179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2015.08.021","volume":"765","author":"YM Suleimani Al","year":"2015","unstructured":"Al Suleimani YM, Al Mahruqi AS, Hiley CR (2015) Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery. Eur J Pharmacol 765:107\u2013114","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"5_CR180","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1111\/bph.12734","volume":"171","author":"LT Kury Al","year":"2014","unstructured":"Al Kury LT, Voitychuk OI, Yang KH, Thayyullathil FT, Doroshenko P, Ramez AM et al (2014) Effects of endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. Br J Pharmacol 171(14):3485\u20133498","journal-title":"Br J Pharmacol"},{"issue":"24","key":"5_CR181","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1093\/emboj\/20.24.7033","volume":"20","author":"J Chemin","year":"2001","unstructured":"Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20(24):7033\u20137040","journal-title":"EMBO J"},{"issue":"1 Pt 2","key":"5_CR182","first-page":"H300","volume":"276","author":"GJ Lagaud","year":"1999","unstructured":"Lagaud GJ, Randriamboavonjy V, Roul G, Stoclet JC, Andriantsitohaina R (1999) Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Phys 276(1 Pt 2):H300\u2013H308","journal-title":"Am J Phys"},{"issue":"5","key":"5_CR183","doi-asserted-by":"publisher","first-page":"H1472","DOI":"10.1152\/ajpheart.00964.2009","volume":"298","author":"J Zhang","year":"2010","unstructured":"Zhang J, Ren C, Chen L, Navedo MF, Antos LK, Kinsey SP et al (2010) Knockout of Na+\/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure. Am J Physiol Heart Circ Physiol 298(5):H1472\u2013H1483","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"5_CR184","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1476-5381.2009.00622.x","volume":"160","author":"N Parmar","year":"2010","unstructured":"Parmar N, Ho WS (2010) N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol 160(3):594\u2013603","journal-title":"Br J Pharmacol"},{"issue":"4","key":"5_CR185","volume":"7","author":"WS Ho","year":"2009","unstructured":"Ho WS, Yeung SYM (2009) Novel G-protein-coupled receptors in rat arteries: potential targets for N-arachidonoyl glycine? Proc Br Pharmacol Soc 7(4):060P","journal-title":"Proc Br Pharmacol Soc"},{"issue":"7","key":"5_CR186","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1073\/pnas.0510676103","volume":"103","author":"G Milman","year":"2006","unstructured":"Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S et al (2006) N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci U S A 103(7):2428\u20132433","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5_CR187","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","volume":"106","author":"M Begg","year":"2005","unstructured":"Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM et al (2005) Evidence for novel cannabinoid receptors. Pharmacol Ther 106(2):133\u2013145","journal-title":"Pharmacol Ther"},{"issue":"24","key":"5_CR188","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1111\/bph.12866","volume":"171","author":"AI Bondarenko","year":"2014","unstructured":"Bondarenko AI (2014) Endothelial atypical cannabinoid receptor: do we have enough evidence? Br J Pharmacol 171(24):5573\u20135588","journal-title":"Br J Pharmacol"},{"key":"5_CR189","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2014.03.055","volume":"735C","author":"J MacIntyre","year":"2014","unstructured":"MacIntyre J, Dong A, Straiker A, Zhu J, Howlett SE, Bagher A et al (2014) Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. Eur J Pharmacol 735C:105\u2013114","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"5_CR190","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bjp.0705643","volume":"141","author":"SE O\u2019Sullivan","year":"2004","unstructured":"O\u2019Sullivan SE, Kendall DA, Randall MD (2004) Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br J Pharmacol 141(5):803\u2013812","journal-title":"Br J Pharmacol"},{"issue":"5","key":"5_CR191","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bjp.0707470","volume":"152","author":"PM Hoi","year":"2007","unstructured":"Hoi PM, Visintin C, Okuyama M, Gardiner SM, Kaup SS, Bennett T et al (2007) Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. Br J Pharmacol 152(5):751\u2013764","journal-title":"Br J Pharmacol"},{"issue":"5","key":"5_CR192","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00424-012-1083-1","volume":"463","author":"M Bol","year":"2012","unstructured":"Bol M, Leybaert L, Vanheel B (2012) Influence of methanandamide and CGRP on potassium currents in smooth muscle cells of small mesenteric arteries. Pflugers Arch 463(5):669\u2013677","journal-title":"Pflugers Arch"},{"issue":"1","key":"5_CR193","doi-asserted-by":"publisher","first-page":"C77","DOI":"10.1152\/ajpcell.00482.2004","volume":"290","author":"H Sade","year":"2006","unstructured":"Sade H, Muraki K, Ohya S, Hatano N, Imaizumi Y (2006) Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. Am J Phys Cell Physiol 290(1):C77\u2013C86","journal-title":"Am J Phys Cell Physiol"},{"key":"5_CR194","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2017.03.038","volume":"805","author":"AI Bondarenko","year":"2017","unstructured":"Bondarenko AI, Panasiuk O, Okhai I, Montecucco F, Brandt KJ, Mach F (2017) Direct activation of Ca2+- and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor. Eur J Pharmacol 805:14\u201324","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"5_CR195","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/bph.13889","volume":"174","author":"D Baker","year":"2017","unstructured":"Baker D, Pryce G, Visintin C, Sisay S, Bondarenko AI, Ho WSV et al (2017) Big conductance calcium-activated potassium channel openers control spasticity without sedation. Br J Pharmacol 174(16):2662\u20132681","journal-title":"Br J Pharmacol"},{"key":"5_CR196","first-page":"312","volume":"5","author":"AM Dopico","year":"2014","unstructured":"Dopico AM, Bukiya AN (2014) Lipid regulation of BK channel function. Front Physiol 5:312","journal-title":"Front Physiol"},{"issue":"15","key":"5_CR197","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1074\/jbc.M116.753350","volume":"292","author":"AN Bukiya","year":"2017","unstructured":"Bukiya AN, Durdagi S, Noskov S, Rosenhouse-Dantsker A (2017) Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus. J Biol Chem 292(15):6135\u20136147","journal-title":"J Biol Chem"},{"issue":"10 Pt A","key":"5_CR198","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.bbamem.2015.07.007","volume":"1848","author":"AN Bukiya","year":"2015","unstructured":"Bukiya AN, Osborn CV, Kuntamallappanavar G, Toth PT, Baki L, Kowalsky G et al (2015) Cholesterol increases the open probability of cardiac KACh currents. Biochim Biophys Acta 1848(10 Pt A):2406\u20132413","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"5_CR199","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.4049\/jimmunol.178.8.5253","volume":"178","author":"KB Kannan","year":"2007","unstructured":"Kannan KB, Barlos D, Hauser CJ (2007) Free cholesterol alters lipid raft structure and function regulating neutrophil Ca2+ entry and respiratory burst: correlations with calcium channel raft trafficking. J Immunol 178(8):5253\u20135261","journal-title":"J Immunol"},{"key":"5_CR200","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.ctm.2017.05.007","volume":"80","author":"SL Morales-Lazaro","year":"2017","unstructured":"Morales-Lazaro SL, Rosenbaum T (2017) Multiple mechanisms of regulation of transient receptor potential ion channels by cholesterol. Curr Top Membr 80:139\u2013161","journal-title":"Curr Top Membr"},{"issue":"6","key":"5_CR201","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ceca.2009.02.006","volume":"45","author":"DJ Beech","year":"2009","unstructured":"Beech DJ, Bahnasi YM, Dedman AM, Al-Shawaf E (2009) TRPC channel lipid specificity and mechanisms of lipid regulation. Cell Calcium 45(6):583\u2013588","journal-title":"Cell Calcium"},{"issue":"2","key":"5_CR202","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2012.05.002","volume":"135","author":"AM Dopico","year":"2012","unstructured":"Dopico AM, Bukiya AN, Singh AK (2012) Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol. Pharmacol Ther 135(2):133\u2013150","journal-title":"Pharmacol Ther"},{"issue":"1","key":"5_CR203","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1085\/jgp.201010519","volume":"137","author":"AN Bukiya","year":"2011","unstructured":"Bukiya AN, Belani JD, Rychnovsky S, Dopico AM (2011) Specificity of cholesterol and analogs to modulate BK channels points to direct sterol-channel protein interactions. J Gen Physiol 137(1):93\u2013110","journal-title":"J Gen Physiol"},{"issue":"14","key":"5_CR204","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/092986710790980087","volume":"17","author":"E Dainese","year":"2010","unstructured":"Dainese E, Oddi S, Maccarrone M (2010) Interaction of endocannabinoid receptors with biological membranes. Curr Med Chem 17(14):1487\u20131499","journal-title":"Curr Med Chem"},{"key":"5_CR205","first-page":"8(2)","volume":"22","author":"C Scala Di","year":"2018","unstructured":"Di Scala C, Fantini J, Yahi N, Barrantes FJ, Chahinian H (2018) Anandamide revisited: how cholesterol and ceramides control receptor-dependent and receptor-independent signal transmission pathways of a lipid neurotransmitter. Biomolecules 22:8(2)","journal-title":"Biomolecules"},{"key":"5_CR206","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.dib.2017.07.024","volume":"14","author":"C Scala Di","year":"2017","unstructured":"Di Scala C, Mazzarino M, Yahi N, Varini K, Garmy N, Fantini J et\u00a0al (2017) Anandamide-ceramide interactions in a membrane environment: molecular dynamic simulations data. Data Brief 14:163\u2013167","journal-title":"Data Brief"},{"key":"5_CR207","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2202-11-44","volume":"11","author":"D McHugh","year":"2010","unstructured":"McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM et al (2010) N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11:44","journal-title":"BMC Neurosci"},{"issue":"18","key":"5_CR208","doi-asserted-by":"publisher","first-page":"12328","DOI":"10.1074\/jbc.M806516200","volume":"284","author":"H Yin","year":"2009","unstructured":"Yin H, Chu A, Li W, Wang B, Shelton F, Otero F et al (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284(18):12328\u201312338","journal-title":"J Biol Chem"},{"issue":"1","key":"5_CR209","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1124\/mol.112.081182","volume":"83","author":"VB Lu","year":"2013","unstructured":"Lu VB, Puhl HL 3rd, Ikeda SR (2013) N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol Pharmacol 83(1):267\u2013282","journal-title":"Mol Pharmacol"},{"key":"5_CR210","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1835","volume":"4","author":"DB Finlay","year":"2016","unstructured":"Finlay DB, Joseph WR, Grimsey NL, Glass M (2016) GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-arachidonoyl glycine. PeerJ 4:e1835","journal-title":"PeerJ"},{"issue":"6","key":"5_CR211","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00125-011-2061-4","volume":"54","author":"AB El-Remessy","year":"2011","unstructured":"El-Remessy AB, Rajesh M, Mukhopadhyay P, Horvath B, Patel V, Al-Gayyar MM et al (2011) Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia 54(6):1567\u20131578","journal-title":"Diabetologia"},{"issue":"3","key":"5_CR212","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh M, Batkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horvath B et al (2012) Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 61(3):716\u2013727","journal-title":"Diabetes"},{"issue":"3","key":"5_CR213","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.00712.x","volume":"160","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, Hasko G, Liaudet L, Mackie K, Pacher P (2010) Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol 160(3):688\u2013700","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"5_CR214","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2826.2008.01685.x","volume":"20","author":"F Mach","year":"2008","unstructured":"Mach F, Steffens S (2008) The role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol 20(Suppl 1):53\u201357","journal-title":"J Neuroendocrinol"},{"issue":"17-18","key":"5_CR215","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.lfs.2007.08.042","volume":"81","author":"P Lepicier","year":"2007","unstructured":"Lepicier P, Lagneux C, Sirois MG, Lamontagne D (2007) Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts. Life Sci 81(17-18):1373\u20131380","journal-title":"Life Sci"},{"issue":"5","key":"5_CR216","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.yjmcc.2008.12.014","volume":"46","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Lenglet S, Braunersreuther V, Burger F, Pelli G, Bertolotto M et al (2009) CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia\/reperfusion. J Mol Cell Cardiol 46(5):612\u2013620","journal-title":"J Mol Cell Cardiol"},{"issue":"1-3","key":"5_CR217","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejphar.2007.09.034","volume":"579","author":"AR Hajrasouliha","year":"2008","unstructured":"Hajrasouliha AR, Tavakoli S, Ghasemi M, Jabehdar-Maralani P, Sadeghipour H, Ebrahimi F et al (2008) Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart. Eur J Pharmacol 579(1-3):246\u2013252","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5_CR218","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/dmrr.1176","volume":"27","author":"C Gonzalez","year":"2011","unstructured":"Gonzalez C, Herradon E, Abalo R, Vera G, Perez-Nievas BG, Leza JC et al (2011) Cannabinoid\/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS\/eNOS. Diabetes Metab Res Rev 27(4):331\u2013340","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"5_CR219","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","volume":"182","author":"IY Choi","year":"2013","unstructured":"Choi IY, Ju C, Anthony Jalin AM, Lee DI, Prather PL, Kim WK (2013) Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury. Am J Pathol 182(3):928\u2013939","journal-title":"Am J Pathol"},{"issue":"7","key":"5_CR220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132487","volume":"10","author":"SJ Yu","year":"2015","unstructured":"Yu SJ, Reiner D, Shen H, Wu KJ, Liu QR, Wang Y (2015) Time-dependent protection of CB2 receptor agonist in stroke. PLoS One 10(7):e0132487","journal-title":"PLoS One"},{"issue":"3","key":"5_CR221","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","volume":"48","author":"P Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, Batkai S et al (2010) Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 48(3):457\u2013467","journal-title":"Free Radic Biol Med"},{"issue":"7034","key":"5_CR222","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nature03389","volume":"434","author":"S Steffens","year":"2005","unstructured":"Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C et al (2005) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434(7034):782\u2013786","journal-title":"Nature"},{"issue":"7","key":"5_CR223","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/eurheartj\/ehr449","volume":"33","author":"F Montecucco","year":"2012","unstructured":"Montecucco F, Di Marzo V, da Silva RF, Vuilleumier N, Capettini L, Lenglet S et al (2012) The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur Heart J 33(7):846\u2013856","journal-title":"Eur Heart J"},{"issue":"3","key":"5_CR224","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","volume":"55","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Yuan Z, Liu Y, Xue J, Tian Y, Liu W et al (2010) Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 55(3):292\u2013298","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"5_CR225","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/bph.13338","volume":"173","author":"P Mukhopadhyay","year":"2016","unstructured":"Mukhopadhyay P, Baggelaar M, Erdelyi K, Cao Z, Cinar R, Fezza F et al (2016) The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. Br J Pharmacol 173(3):446\u2013458","journal-title":"Br J Pharmacol"},{"issue":"12","key":"5_CR226","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","volume":"32","author":"SH Ramirez","year":"2012","unstructured":"Ramirez SH, Hasko J, Skuba A, Fan S, Dykstra H, McCormick R et al (2012) Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. J Neurosci 32(12):4004\u20134016","journal-title":"J Neurosci"},{"issue":"1","key":"5_CR227","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/14796678.2.1.49","volume":"2","author":"S Steffens","year":"2006","unstructured":"Steffens S, Mach F (2006) Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis. Futur Cardiol 2(1):49\u201353","journal-title":"Futur Cardiol"},{"issue":"2","key":"5_CR228","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50(2):193\u2013211","journal-title":"Prog Lipid Res"},{"key":"5_CR229","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.nucmedbio.2017.01.001","volume":"47","author":"R Meletta","year":"2017","unstructured":"Meletta R, Slavik R, Mu L, Rancic Z, Borel N, Schibli R et al (2017) Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis. Nucl Med Biol 47:31\u201343","journal-title":"Nucl Med Biol"},{"issue":"6","key":"5_CR230","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1189\/jlb.0307180","volume":"82","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Pan H, Mukhopadhyay P, Batkai S, Osei-Hyiaman D, Hasko G et al (2007) Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia\/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 82(6):1382\u20131389","journal-title":"J Leukoc Biol"},{"key":"5_CR231","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.prostaglandins.2018.09.001","volume":"138","author":"M Biernacki","year":"2018","unstructured":"Biernacki M, Malinowska B, Timoszuk M, Toczek M, Jastrzab A, Remiszewski P et al (2018) Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. Prostaglandins Other Lipid Mediat 138:54\u201363","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"5_CR232","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1478-3231.2004.0945.x","volume":"24","author":"CM Fernandez-Rodriguez","year":"2004","unstructured":"Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML et al (2004) Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. Liver Int 24(5):477\u2013483","journal-title":"Liver Int"},{"issue":"4","key":"5_CR233","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gut.2004.051599","volume":"54","author":"M Domenicali","year":"2005","unstructured":"Domenicali M, Ros J, Fern\u00e1ndez-Varo G, Cejudo-Mart\u00edn P, Crespo M, Morales-Ruiz M et al (2005) Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 54(4):522\u2013527","journal-title":"Gut"},{"issue":"8","key":"5_CR234","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1478-3231.2007.01551.x","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Lin H, Huang Y, Lee T, Hou M, Wang Y et al (2007) Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis. Liver Int 27(8):1045\u20131055","journal-title":"Liver Int"},{"issue":"1","key":"5_CR235","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1476-5381.2008.00034.x","volume":"156","author":"WS Ho","year":"2009","unstructured":"Ho WS, Gardiner SM (2009) Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. Br J Pharmacol 156(1):94\u2013104","journal-title":"Br J Pharmacol"},{"issue":"5","key":"5_CR236","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.bjp.0707410","volume":"152","author":"AJ Wheal","year":"2007","unstructured":"Wheal AJ, Bennett T, Randall MD, Gardiner SM (2007) Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. Br J Pharmacol 152(5):717\u2013724","journal-title":"Br J Pharmacol"},{"issue":"10","key":"5_CR237","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.2042-7158.1975.tb09406.x","volume":"27","author":"DR Varma","year":"1975","unstructured":"Varma DR, Goldbaum D (1975) Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats. J Pharm Pharmacol 27(10):790\u2013791","journal-title":"J Pharm Pharmacol"},{"key":"5_CR238","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fphar.2017.00248","volume":"8","author":"AJ Wheal","year":"2017","unstructured":"Wheal AJ, Jadoon K, Randall MD, O\u2019Sullivan SE (2017) In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats. Front Pharmacol 8:248","journal-title":"Front Pharmacol"},{"issue":"5","key":"5_CR239","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","volume":"36","author":"K Mishima","year":"2005","unstructured":"Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K et al (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36(5):1077\u20131082","journal-title":"Stroke"},{"issue":"5","key":"5_CR240","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","volume":"102","author":"K Hayakawa","year":"2007","unstructured":"Hayakawa K, Mishima K, Nozako M, Hazekawa M, Irie K, Fujioka M et al (2007) Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism. J Neurochem 102(5):1488\u20131496","journal-title":"J Neurochem"},{"issue":"8","key":"5_CR241","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.neuropharm.2008.06.040","volume":"55","author":"K Hayakawa","year":"2008","unstructured":"Hayakawa K, Mishima K, Irie K, Hazekawa M, Mishima S, Fujioka M et al (2008) Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism. Neuropharmacology 55(8):1280\u20131286","journal-title":"Neuropharmacology"},{"issue":"25","key":"5_CR242","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","volume":"56","author":"M Rajesh","year":"2011","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S et al (2011) Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 56(25):2115\u20132125","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5_CR243","doi-asserted-by":"publisher","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Drel VR et al (2007) Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 293(1):H610\u2013H619","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"5_CR244","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2009","unstructured":"Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150(5):613\u2013623","journal-title":"British Journal of Pharmacology"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances in Cannabinoid Physiology and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-21737-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T07:39:04Z","timestamp":1721547544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-21737-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030217365","9783030217372"],"references-count":244,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-21737-2_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"23 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}